Revolutionising cellular therapies for cancer and beyond
We’re developing more precise and more accessible treatment options for patients with solid cancers, endometriosis and Alzheimer’s disease
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.
Some of our partners
Latest news
Cartherics welcomes doctoral student Van Thi To
By Christine Filippis / December 5, 2019
Listen to Van and Graham here : Hi from Van and Graham Pictured from left to right : Professor Richard Boyd...
Read More
“Who mattered in 2019? When it comes to Science the answer is Cartherics Scientific Advisor Jacques Miller, according to The Age and The Sydney Morning Herald”.
By Christine Filippis / December 3, 2019
Akshay Venkatesh: this Perth-raised mathematician and professor is "one of Australia’s greatest minds". Plus: Lisa Harvey-Smith and Jacques Miller. Good...
Read More
Cartherics CEO Alan Trounson answers questions on treating cancer – ‘Can we enclose cancer before it spreads?’
By Christine Filippis / November 26, 2019
As part of the Australian Academy of Technology and Engineering’s (ATSE) Ask an Expert series from our newsletter #TechKnow, Professor Alan Trounson...
Read More
